497 results on '"Pirsch, J"'
Search Results
2. Long-Term Pancreatic Allograft Survival After Renal Retransplantation in Prior Simultaneous Pancreas–Kidney Recipients
3. A Randomized, Double-Blind, Pharmacokinetic Study of Oral Maribavir with Tacrolimus in Stable Renal Transplant Recipients
4. New-Onset Diabetes After Transplantation: Results From a Double-Blind Early Corticosteroid Withdrawal Trial
5. Phase 1 Dose-Escalation Study of CP-690 550 in Stable Renal Allograft Recipients: Preliminary Findings of Safety, Tolerability, Effects on Lymphocyte Subsets and Pharmacokinetics
6. Predictors of Kidney Graft and Patient Outcomes in the Elderly, Obese, Diabetic Population.: Abstract# B914
7. Statins are associated with improved outcomes of bloodstream infection in solid-organ transplant recipients
8. Blood pressure control in kidney transplantation: therapeutic implications
9. Acute Cellular and Antibody-Mediated Rejection of the Pancreas Allograft: Incidence, Risk Factors and Outcomes
10. Effect of Corticosteroid Withdrawal on Tacrolimus and Mycophenolate Mofetil Exposure in a Randomized Multicenter Study
11. Factors Influencing Kidney Allograft Survival after 10 Years.: Abstract# 1561: Poster Board #-Session: P123-IV
12. Outcome after Grade II or Higher Rejection of the Pancreas.: Abstract# 786 Poster Board #-Session: P254-I
13. Effect of Pre Transplant Coronary Artery Disease (CAD) on Simultaneous Pancreas and Kidney (SPK) Survival.: Abstract# 785 Poster Board #-Session: P253-I
14. Thymoglobulin Versus Basiliximab Induction in Sensitized Deceased Donor Kidney Transplant Recipients: Short-Term Follow-Up.: Abstract# 676 Poster Board #-Session: P144-I
15. Serum Beta-2 Microglobulin at Discharge Predicts Outcomes after Kidney Transplantation.: Abstract# 464
16. The Significance of Donor-Specific HLA Antibodies in Rejection and Ductopenia Development in ABO Compatible Liver Transplantation
17. Paraganglioma of the neck - Importance of Genetic Analysis for SDH mutation: PO442
18. Incidence of and Risk Factors for Posttransplant Diabetes Mellitus after Pancreas Transplantation
19. Conversion of Stable Kidney Transplant Recipients From a Twice Daily Prograf-Based Regimen to a Once Daily Modified Release Tacrolimus-Based Regimen
20. A Comparison of Alemtuzumab with Basiliximab Induction in Simultaneous Pancreas–Kidney Transplantation
21. Polarität, molare Schmelzwärme und Schmelzpunktslage organischer Verbindungen. Polymorphe Umwandlungen im Schmelzpunktsbereich und deren Umwandlungswärmen
22. Molekulargewichtsbestimmung
23. Organische Verbindungen mit hohen molaren Schmelzpunkts-Erniedrigungen für die Laboratoriumspraxis
24. Beitrag zur Frage der Gitterkräfte organischer Moleküle: Schmelzpunktslage, molare Schmelzwärme, Schmelzentropie uud Raumbau organischer Verbindungen
25. Notiz zur Darstellung von Cyclopenten-3,4- und-3,5-diol
26. Molekulargewichtsbetstimmungen
27. Der zusätzliche Einfluß der Ringanzahl in sphärisch gebauten organischen Verbindungen für die Größe der molaren Schmelzwärme
28. Bemerkenswerte Umsetzungen in der Dicyclopentadienreihe
29. Cyclische Monoäther von sphärischem Raumbau zur Kryoskopie
30. Zur Konstitution einer Verbindung C5H2Br2O2 und ihres Adduktes mit Cyclopentadien: Vorläufige Mitteilung
31. Predictors of Kidney Graft and Patient Outcomes in the Elderly, Obese, Diabetic Population.
32. Inflammatorisches abdominelles Aortenaneurysma - Prognoseverbesserung durch Screening?
33. UROLOGICAL COMPLICATIONS AND ENTERIC CONVERSION AFTER PANCREAS TRANSPLANTATION WITH BLADDER DRAINAGE
34. DONOR SMALL VESSEL DISEASE AND INTERSTITIAL FIBROSIS CORRELATE WITH SHORT TERM KIDNEY ALLOGRAFT DYSFUNCTION
35. ALEMTUZUMAB DOES NOT INCREASE THE RISK OF BK VIRURIA OR VIREMIA FOLLOWING KIDNEY, SIMULTANEOUS KIDNEY-PANCREAS, OR PANCREAS AFTER KIDNEY TRANSPLANTATION.
36. POST-TRANSPLANT STAGE PROGRESSION IN LIVER TRANSPLANT RECIPIENTS WITH CHRONIC KIDNEY DISEASE (CKD): SINGLE CENTER ANALYSIS WITH 10 YEARS OF FOLLOW-UP
37. A TRIAL OF MYCOPHENOLATE MONOTHERAPY IN HLA IDENTICAL SIBLING RENAL TRANSPLANTATION
38. Increase in proteinuria >200 mg/g after late rejection is associated with poor graft survival
39. MYFORTIC VS. CELLCEPT: A LARGE, SINGLE-CENTER COMPARISON
40. ANTIBODY-MEDIATED REJECTION OF THE KIDNEY AFTER SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION (SPKT): ALEMTUZUMAB IS NOT SUPERIOR TO BASILIXIMAB AS INDUCTION TREATMENT
41. ANTIBODY-MEDIATED REJECTION IN RENAL ALLOGRAFT RECIPIENTS TREATED WITH ALEMTUZUMAB INDUCTION
42. ACUTE ANTIBODY-MEDIATED REJECTION (AMR) OF THE KIDNEY ALLOGRAFT: IS THERE ANY DIFFERENCE IN OUTCOMES IN FOCAL VS DIFFUSE C4D STAINING CASES?
43. PREDICTORS OF NEW ONSET DIABETES AFTER PANCREAS TRANSPLANT
44. C4D POSITIVE INTERACINAR CAPILLARIES CORRELATES WITH DONOR-SEPCIFIC ANTIBODY MEDIATED REJECTION IN PANCREAS ALLOGRAFTS CORRE
45. Predictors and Outcomes of Candiduria in Renal Transplant Recipients
46. Infected Bilomas in Liver Transplant Recipients: Clinical Features, Optimal Management, and Risk Factors for Mortality
47. ALEMTUZUMAB IMPROVES OUTCOMES IN RENAL TRANSPLANTATION
48. Donation after Cardiac Death A viable method to increase organ availability for Simultaneous Pancreas-Kidney Transplantation.
49. The Impact of Pancreas Transplantation on Mortality and Kidney Allograft Survival: Retransplantation Compared with Primary Transplants
50. Superior Long Term Results of Kidney Transplants from Simultaneous Pancreas-Kidney Transplantation (SPK) from Pediatric Donors Compared to Diabetic recipients of Living Related Kidney Transplant.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.